세계의 심장 초음파 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Intracardiac Echocardiography (ICE) Market Summary

The global intracardiac echocardiography market size was estimated at USD 5.29 billion in 2024 and is projected to reach USD 8.54 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. Rising prevalence of cardiovascular disease is anticipated to boost market growth.

According to an International Journal of Basic & Clinical Pharmacology article published in June 2025, the global age-standardized prevalence of cardiovascular disease, estimated at around 7,179 cases per 100,000 people, highlights the persistent and widespread impact of heart conditions, which in turn is driving greater reliance on advanced imaging technologies such as intracardiac echocardiography (ICE). The burden of cardiovascular disorders continues to rise, and the demand for precise imaging during procedures such as atrial fibrillation ablation, transcatheter valve repair, and left atrial appendage closure is growing steadily. ICE is increasingly valued for its ability to provide high-resolution, real-time visualization from within the heart, reducing the need for more invasive approaches and enhancing procedural safety and efficiency.

The rising prevalence of cardiovascular diseases (CVDs) in the U.S., including conditions such as arrhythmias and heart failure, is significantly driven by several key factors. A sedentary lifestyle has become increasingly common, with many individuals engaging in insufficient physical activity, which contributes to obesity and related health issues. According to the American Heart Association, in January 2024, in the U.S., cardiovascular disease accounted for 931,578 deaths, which was nearly 3,000 more than the year before. The age-adjusted mortality rate rose to 233.3 per 100,000 people, marking a 4% increase compared with the previous year.

The growing prevalence of Arrhythmias drives the growth of the market. According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people worldwide are currently affected by atrial fibrillation (AFib), making it one of the most common and challenging cardiac conditions to manage. With an estimated one in four adults over the age of 40 likely to develop AFib during their lifetime, the demand for safe and effective treatment options continues to grow.

Projections indicating a 60% increase in AFib cases between 2024 and 2060 further highlight the urgency for advanced solutions. In this context, intracardiac echocardiography (ICE) is gaining importance as it offers real-time, high-resolution imaging that enhances the precision and safety of catheter ablation procedures, a primary treatment for AFib. Therefore, the rising prevalence of this arrhythmia is a key factor driving the adoption of ICE systems and catheters in electrophysiology labs and interventional centers worldwide.

Global Intracardiac Echocardiography Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the Intracardiac Echocardiography (ICE) market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• ICE Ultrasound Systems with Inbuilt Software
  • 2D Ultrasound Systems
  • 3D / 4D Ultrasound Systems
  • Doppler Ultrasound Systems
• ICE Catheters
  • Doppler ICE Catheters
  • Phased-array ICE Catheters
  • Fixed-array ICE Catheters
  • Mechanical / Rotational ICE Catheters
• ICE Consoles
  • Cart/Trolley-based Consoles
  • Hand-held / Portable Consoles
• Guiding Catheters & Sheaths
• Disposable Accessories
• Software
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Electrophysiology (EP) Procedures
• Structural Heart Defects
• Left Atrial Appendage Closure (LAAC)
• Cardiac Monitoring
• Other Applications
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Surgical Centers (Diagnostic)
• Hospital-based Cath Labs / Hybrid or Interventional Centers
• Ambulatory Surgical Centers (ASCs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Intracardiac Echocardiography (ICE) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of CVD
    • 3.2.1.2. Increasing incidence of arrhythmia
    • 3.2.1.3. Technologically advanced product launches
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced ICE and surgical procedures
    • 3.2.2.2. Stringent regulatory approval processes delaying product launches
• 3.3. Trauma devices: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Framework
• 3.5. Technology Landscape
• 3.6. Case Study Analysis

Chapter 4. Intracardiac Echocardiography (ICE) Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Intracardiac Echocardiography (ICE) Market, by Type, 2021 to 2033
• 4.5. ICE Ultrasound Systems with Inbuilt Software
  • 4.5.1. ICE ultrasound systems with inbuilt software market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. 2D Ultrasound Systems
    • 4.5.2.1. 2D ultrasound systems market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. 3D / 4D Ultrasound Systems
    • 4.5.3.1. 3D / 4D ultrasound systems market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.4. Doppler Ultrasound Systems
    • 4.5.4.1. Doppler ultrasound systems market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. ICE Catheters
  • 4.6.1. ICE catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Doppler ICE Catheters
    • 4.6.2.1. Doppler ICE catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Phased-Array ICE Catheters
    • 4.6.3.1. Phased-Array ICE catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. Fixed-Array ICE Catheters
    • 4.6.4.1. Fixed-array ICE catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.5. Mechanical / Rotational ICE Catheters
    • 4.6.5.1. Mechanical / Rotational ICE catheters market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. ICE Consoles
  • 4.7.1. ICE consoles market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.2. Cart/Trolley-based Consoles
    • 4.7.2.1. Cart/Trolley-based consoles market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.3. Hand-held / Portable Consoles
    • 4.7.3.1. Hand-held / Portable consoles market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Guiding Catheters & Sheaths
  • 4.8.1. Guiding catheters & sheaths market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Disposable Accessories
  • 4.9.1. Disposable accessories market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.10. Software
  • 4.10.1. Software market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Intracardiac Echocardiography (ICE) Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Surgical Site Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Intracardiac Echocardiography (ICE) Market, by Surgical Site, 2021 to 2033
• 5.5. Electrophysiology (EP) Procedures
  • 5.5.1. Electrophysiology (EP) Procedures market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Structural Heart Defects
  • 5.6.1. Structural heart defects market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Left Atrial Appendage Closure (LAAC)
  • 5.7.1. Left Atrial Appendage Closure (LAAC) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Cardiac Monitoring
  • 5.8.1. Cardiac Monitoring market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Other Applications
  • 5.9.1. Other applications market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Intracardiac Echocardiography (ICE) Market Segment Analysis, By End-use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End-use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global ICE Market, by end-use, 2021 to 2033
• 6.5. Hospitals & Surgical Centers
  • 6.5.1. Hospitals & surgical centers market estimates and forecasts, 2021 to 2033 (USD million)
• 6.6. Hospital-based Cath Labs / Hybrid or Interventional Centers
  • 6.6.1. Hospital-based cath labs / hybrid or interventional centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Ambulatory Surgical Centers (ASCs)
  • 6.7.1. Ambulatory Surgical Centers (ASCs) market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Intracardiac Echocardiography (ICE) Market Segment Analysis, By Region, By Product, By Application, By End Use, 2021 - 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Intracardiac Echocardiography (ICE) Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait Intracardiac Echocardiography (ICE) market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Siemens Healthineers
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Koninklijke Philips N.V.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Abbott Laboratories
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Johnson & Johnson MedTech
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Boston Scientific Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. GE Healthcare
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Medtronic plc
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Stereotaxis, Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. FUJIFILM Holdings America Corporation
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Shifamed, LLC
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives